Journal: | Revista de investigación clínica |
Database: | PERIÓDICA |
System number: | 000452983 |
ISSN: | 0034-8376 |
Authors: | Núñez, Isaac1 Belaunzarán Zamudio, Pablo F3 Caro Vega, Yanink2 |
Institutions: | 1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Departamento de Educación Médica, Ciudad de México. México 2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Departamento de Enfermedades Infecciosas, Ciudad de México. México 3National Institutes of Health, National Institute of Allergy and Infectious Diseases,, Bethesda. Estados Unidos |
Year: | 2022 |
Season: | Mar-Abr |
Volumen: | 74 |
Number: | 2 |
Pages: | 71-80 |
Country: | México |
Language: | Inglés |
Document type: | Artículo |
Approach: | Aplicado, descriptivo |
English abstract | Delay in COVID-19 diagnosis due to late real-time reverse transcription-polymerase chain reaction reporting has been described to be an important cause of suboptimal COVID-19 surveillance and outbreak containment. Objective: The objective of the study was to determine the duration of diagnostic delay due to test turnaround time and its association with marginalization status. Methods: In this observational study using national open data of Mexico and Colombia, we quantified the delay in COVID-19 diagnosis that occurred in both countries. We considered two periods that contributed to the delay in diagnosis: the time from symptom onset until testing (delay-one) and test turnaround time (delay-two). Marginalization status was determined according to country-specific scores. Results: Among 3,696,773 patients from Mexico and Colombia, delay-two was generally longer than delay-one. Median delay-one was 3 days and delay-two 7 days in Colombia, while in Mexico, they were 3 days and 4 days, respectively. In Colombia, worse marginalization status prolonged delay-two. In Mexico, a lower number and percentage of rapid tests were performed in areas with worse marginalization. Conclusion: Diagnostic delay was mostly due to test turnaround time. Marginalization status was an important barrier to diagnostic test access |
Disciplines: | Medicina |
Keyword: | Diagnóstico, SARS-CoV-2, COVID-19, Reacción en cadena de la polimerasa (PCR) |
Keyword: | Diagnosis, SARS-CoV-2, COVID-19, Polymerase chain reaction (PCR) |
Full text: | Texto completo (Ver HTML) Texto completo (Ver PDF) |